Frederick, MD, United States of America

Josip Blonder

This inventor holds 2 USPTO granted patents. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2014-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Josip Blonder. Retrieved from https://idiyas.com/inventor/josip-blonder

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Josip Blonder: Innovator in Tumor Biomarker Identification

Introduction

Josip Blonder is a notable inventor based in Frederick, MD (US). He has made significant contributions to the field of medical diagnostics, particularly in identifying biomarkers for renal cell carcinoma. With a total of 2 patents, his work is paving the way for advancements in cancer detection and treatment.

Latest Patents

Blonder's latest patents focus on methods for identifying tumor biomarkers. One of his key innovations involves obtaining a peripheral biological fluid sample from a subject with a tumor, alongside a tumor sample and an adjacent non-tumor sample. By detecting and comparing protein expression profiles in these samples, he has developed a method to identify specific proteins that serve as biomarkers for tumors. Additionally, his patents disclose a gene profiling signature that can be utilized for diagnosing renal cell carcinoma (RCC) and for identifying therapeutic agents to treat this condition.

Career Highlights

Josip Blonder has been associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work has been instrumental in advancing the understanding of renal cell carcinoma and improving diagnostic methods.

Collaborations

Blonder has collaborated with esteemed colleagues such as Bih-Rong Wei and Donald J Johann, Jr. These partnerships have further enhanced the research and development of innovative solutions in the medical field.

Conclusion

Josip Blonder's contributions to the identification of tumor biomarkers represent a significant advancement in cancer diagnostics. His innovative methods and collaborative efforts are crucial in the ongoing fight against renal cell carcinoma.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…